IMPAVIDO
Active substance: miltefosine
CAPSULE · MILTEFOSINE 50 mg/1
United StatesActive
Marketing holder: Eton Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- MILTEFOSINE · 50 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12099-adb7-72f6-bcf0-010c113cd8fc;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 71863-135
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 71863-135 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 71863-135 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 71863-135 · Verified 2026-10-09 · open in source